M

Marrone Bio Innovations Inc
F:0MB

Watchlist Manager
Marrone Bio Innovations Inc
F:0MB
Watchlist
Price: 0.965 EUR -3.02%
Market Cap: 176m EUR

Operating Margin
Marrone Bio Innovations Inc

-39.2%
Current
-60%
Average
5.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-39.2%
=
Operating Profit
-17.4m
/
Revenue
44.4m

Operating Margin Across Competitors

No Stocks Found

Marrone Bio Innovations Inc
Glance View

Market Cap
175.9m EUR
Industry
Chemicals

Marrone Bio Innovations, Inc. engages in the provision of biological-based solutions for agricultural crops, turf protection, seed treatment, plant health and waterway systems. The company is headquartered in Raleigh, North Carolina and currently employs 153 full-time employees. The company went IPO on 2013-08-02. The Company’s products include Emergen, Foramin, Foramin ST, Grandevo, Haven, Jet-Ag, Jet-Oxide, Majestene, Pacesetter, Regalia, Stargus, UBP, UBP ST, Venerate and Zelto. Its product categories include products, which are referred to as biopesticides, bioinsecticides, bionematicides, biofungicides, biostimulants and bionutrition. Its pipeline consists of products in three categories: bioprotection, seed and soil health, and plant health. The Company’s markets include row crops, such as corn and soybeans; fruits and vegetables, such as tomatoes, leafy greens and cucurbits, trees; nuts and vines, such as almonds and grapes, and greenhouse production, such as ornamentals and medicinal plants.

0MB Intrinsic Value
Not Available
M
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-39.2%
=
Operating Profit
-17.4m
/
Revenue
44.4m
What is the Operating Margin of Marrone Bio Innovations Inc?

Based on Marrone Bio Innovations Inc's most recent financial statements, the company has Operating Margin of -39.2%.

Back to Top